10x Genomics, Inc. TXG
Nasdaq · XNAS · stock · Laboratory Analytical Instruments · website · IPO 2019-09-12
Chart by TradingView
4/9
Piotroski F — financial health
1.63
Altman Z″ — distress risk · grey
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $642.8M | $610.8M | $618.7M | $516.4M | $490.5M |
| Gross profit | $443.9M | $414.5M | $409.3M | $396.0M | $416.4M |
| Operating income | -$61.0M | -$194.6M | -$265.3M | -$167.9M | -$52.3M |
| Net income | -$43.5M | -$182.6M | -$255.1M | -$166.0M | -$58.2M |
| Operating cash flow | $136.1M | $6.7M | -$15.2M | -$33.6M | -$21.4M |
| Free cash flow | $130.1M | -$5.7M | -$63.8M | -$165.3M | -$122.7M |
| Total assets | $1.0B | $918.6M | $965.1M | $1.0B | $1.0B |
| Total liabilities | $245.0M | $208.5M | $224.1M | $223.2M | $201.3M |
| Shareholders' equity | $796.3M | $710.1M | $741.0M | $805.7M | $817.6M |
| Ratios | |||||
| Gross margin | 69.1% | 67.9% | 66.2% | 76.7% | 84.9% |
| Operating margin | -9.5% | -31.9% | -42.9% | -32.5% | -10.7% |
| Net margin | -6.8% | -29.9% | -41.2% | -32.1% | -11.9% |
| FCF margin | 20.2% | -0.9% | -10.3% | -32.0% | -25.0% |
| Return on assets | -4.2% | -19.9% | -26.4% | -16.1% | -5.7% |
| Return on equity | -5.5% | -25.7% | -34.4% | -20.6% | -7.1% |
| Current ratio | 4.46 | 4.97 | 4.69 | 4.85 | 6.77 |
| Revenue growth | 5.2% | -1.3% | 19.8% | 5.3% | 64.1% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| ARK Investment Management LLC | 11,717,317 | $248.8M |
| RENAISSANCE TECHNOLOGIES LLC | 1,008,739 | $21.4M |
| Bridgewater Associates, LP | 35,101 | $745,194 |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 1.63 (grey)
- Working capital / assets 0.51
- Retained earnings / assets -1.451
- EBIT / assets -0.059
- Equity / liabilities 3.25
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001770787 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.